The Oncology Institute, Inc. (TOI)

The Oncology Institute Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	30.28	33.57	49.67	33.49	14.01	115.17
Short-Term Investments	-	-	-	49.37	59.8	-
Cash & Short-Term Investments	30.28	33.57	49.67	82.86	73.81	115.17
Cash Growth	-23.80%	-32.42%	-40.05%	12.26%	-35.92%	1820.21%
Accounts Receivable	58.13	59	48.34	42.36	39.82	20.01
Other Receivables	1.32	0.32	0.35	0.55	0.62	1.24
Total Trade Receivables	59.45	59.32	48.68	42.91	40.43	21.24
Inventory	24.29	16.88	10.04	13.68	9.26	6.44
Other Current Assets	2.84	2.99	4.03	4.05	6.92	11.2
Total Current Assets	116.86	112.75	112.42	143.49	130.42	154.06
Net Property, Plant & Equipment	33.22	33.06	37.67	40.05	33.04	4.19
Other Intangible Assets	10.3	11.02	14.81	17.9	17.96	18.25
Goodwill	7.23	7.23	7.23	7.23	21.42	26.63
Long-Term Investments	-	-	-	-	58.35	-
Other Long-Term Assets	0.62	0.61	0.59	0.56	0.48	0.32
Total Assets	168.23	164.66	172.72	209.24	261.67	203.44

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	47.65	43.17	24.32	14.43	9.37	15.56
Accrued Expenses	24.3	20.64	21.09	14	14.85	14.06
Current Portion of Long-Term Debt	-	-	-	-	-	0.18
Current Portion of Leases	7.4	7.16	6.8	6.36	5.5	-
Total Current Liabilities	79.35	70.96	52.22	34.79	29.72	29.8
Long-Term Debt	78.61	77.4	93.13	86.83	80.62	-
Long-Term Leases	18.84	19.13	23.22	26.49	22.06	-
Other Long-Term Liabilities	7.71	12.88	0.56	4.12	6.09	69.48
Total Long-Term Liabilities	105.16	109.41	116.91	117.43	108.77	69.48
Total Liabilities	184.52	180.38	169.13	152.22	138.49	99.28

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0	0.01
Treasury Stock	-1.02	-1.02	-1.02	-1.02	-	-
Additional Paid-in Capital	258.64	256.71	215.41	204.19	186.25	167.39
Retained Earnings	-273.91	-271.42	-210.81	-146.15	-63.08	-63.23
Total Common Shareholders' Equity	-16.29	-15.72	3.59	57.03	123.18	104.16
Shareholders' Equity	-16.29	-15.72	3.59	57.03	123.17	104.16
Total Liabilities & Equity	168.23	164.66	172.72	209.24	261.67	203.44

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	104.86	103.69	123.15	119.68	108.18	0.18
Net Cash (Debt)	-74.58	-70.12	-73.48	-36.82	-34.37	114.99
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.76	-0.76	-0.98	-0.50	-0.43	1.74
Book Value	-16.29	-15.72	3.59	57.03	123.18	104.16
Book Value Per Share	-0.17	-0.17	0.05	0.77	1.53	1.57
Tangible Book Value	-33.82	-33.97	-18.45	31.89	83.8	59.29
Tangible Book Value Per Share	-0.34	-0.37	-0.25	0.43	1.04	0.90

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error